Additional UConn Information

  • 12/10 CRC Seminar - Annabelle Rodriguez-Oquendo, M.D.

    The Lowell P. Weicker, Jr.
    Clinical Research Center (CRC) Seminar Series
    On Methods in Clinical Research

    Sponsored by the University of Connecticut School of Medicine
    Office of Community and Continuing Medical Education and the Clinical Research Center

    A Novel Link Between Lipid Metabolism and Female” Infertility: SR-BI”

    Annabelle Rodriguez-Oquendo, M.D., F.A.H.A.

    Linda and David Roth Chair of Cardiovascular Research
    Professor of Cell Biology
    University of Connecticut Health Center
    Farmington, CT

    Date:            Tuesday, December 10, 2013
    Time:           12:00 Noon – 1:00 P.M.
    Location:     Low Learning Center – UCHC, Farmington, CT 

    WEB CASThttp://mediasite.uchc.edu/mediasite41/Catalog/Full/8ae6f507dcf6496291465484f6db849921
    (Note:  No CME’s given for Web Cast viewing)

    Light lunch and beverage provided

    Target Audience: Faculty, staff, residents, and students interested in clinical research. 

    Learning Objectives: Participants will (be able to):

    a. Learn about the SCARB1 gene
    b. Learn about genetic variations and association with heart disease and infertility
    c. Be clinically prepared when the genetic tests for SCARB1 become available

    Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The University of Connecticut School of Medicine designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Conflict of Interest Policy: All faculty members participating in CME activities sponsored by the University of Connecticut  School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations.  Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

    The Activity Director and planning committee members do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. 

    Dr. Rodriguez-Oquendo has a financial interest/arrangement with Iverson Genetics (inventor for SCARBI molecular diagnostics) that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.  The following safeguard has been put in place to avoid the insertion of commercial bias into the content:  The activity director peer-reviewed the content of the presentation to ensure that no commercial bias exists.  Dr. Rodriguez-Oquendo will be discussing the off-label use of - SCARB1 molecular diagnostics.

    This CME activity has no commercial support associated with it.  Food and refreshments provided by the CRC.

     

    For more information, contact: Lisa Godin at Godin@nso.uchc.edu